{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-008179","form_type":"8-K","ticker":null,"cik":"0001289850","company_name":"NeuroMetrix, Inc.","filed_at":"2025-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.851639+00:00","generated_at":"2026-05-22T22:18:35.961196+00:00","sec_items":["1.02","2.01","3.01","3.03","5.01","5.02","5.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"NeuroMetrix completes merger with electroCore; shareholders receive $4.49/share plus CVRs","bullets":["Merger closed on May 1, 2025; shareholders receive $4.49 per share cash plus contingent value rights.","CVRs tied to future proceeds from Quell product line and asset purchase agreements with Fukuda Denshi and Alera/Impulse.","Common stock to be delisted from Nasdaq; registration under Section 12(g) to be terminated.","Board and officers replaced; Dan Goldberger becomes CEO, Joshua Lev CFO of surviving corporation.","Employee Stock Purchase Plan terminated effective May 1, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-008179","json":"https://secwatch.observer/filing/0001641172-25-008179.json","markdown":"https://secwatch.observer/filing/0001641172-25-008179.md","text":"https://secwatch.observer/filing/0001641172-25-008179.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T22:18:35.961196+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1b634e0385","claim":"Joshua Horowitz departed as Director at NeuroMetrix, Inc..","evidence_excerpt":"In connection with the consummation of the Merger, each of Shai N. Gozani, David Van Avermaete, David E. Goodman, Joshua Horowitz and Nancy E. Katz ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"2e1292464d","claim":"David Van Avermaete departed as Director at NeuroMetrix, Inc..","evidence_excerpt":"In connection with the consummation of the Merger, each of Shai N. Gozani, David Van Avermaete, David E. Goodman, Joshua Horowitz and Nancy E. Katz ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"36d24bf713","claim":"Shai N. Gozani departed as Director at NeuroMetrix, Inc..","evidence_excerpt":"In connection with the consummation of the Merger, each of Shai N. Gozani, David Van Avermaete, David E. Goodman, Joshua Horowitz and Nancy E. Katz ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"47dc64ba28","claim":"Dan Goldberger was appointed as Chief Executive Officer at NeuroMetrix, Inc..","evidence_excerpt":"Dan Goldberger became the Chief Executive Officer of the Surviving Corporation","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"became"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"513b7da8e7","claim":"Dan Goldberger was appointed as Director at NeuroMetrix, Inc..","evidence_excerpt":"At the Effective Time, in connection with the consummation of the Merger, and pursuant to the Merger Agreement each of Dan Goldberger and Joshua Lev (the directors of Merger Sub immediately prior to the Effective Time) became the directors of the Surviving Corporation in lieu of the Company’s existing directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"became"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"848ca0b567","claim":"Joshua Lev was appointed as Director at NeuroMetrix, Inc..","evidence_excerpt":"At the Effective Time, in connection with the consummation of the Merger, and pursuant to the Merger Agreement each of Dan Goldberger and Joshua Lev (the directors of Merger Sub immediately prior to the Effective Time) became the directors of the Surviving Corporation in lieu of the Company’s existing directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"became"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b6a98da1e6","claim":"Joshua Lev was appointed as Chief Financial Officer at NeuroMetrix, Inc..","evidence_excerpt":"Joshua Lev became the Chief Financial Officer of the Surviving Corporation","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"became"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"ba87953b0a","claim":"Nancy E. Katz departed as Director at NeuroMetrix, Inc..","evidence_excerpt":"In connection with the consummation of the Merger, each of Shai N. Gozani, David Van Avermaete, David E. Goodman, Joshua Horowitz and Nancy E. Katz ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d9f22f4fca","claim":"David E. Goodman departed as Director at NeuroMetrix, Inc..","evidence_excerpt":"In connection with the consummation of the Merger, each of Shai N. Gozani, David Van Avermaete, David E. Goodman, Joshua Horowitz and Nancy E. Katz ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"94f86f4e6c032d1e0fb66f23ee0337dc9acc1702","claim":"NeuroMetrix, Inc.: The Surviving Corporation adopted the Fourth Amended and Restated Certificate of Incorporation in connection with the Merger.","evidence_excerpt":"At the Effective Time and in connection with the Merger, the Surviving Corporation adopted the Fourth Amended and Restated Certificate of Incorporation, in the form attached hereto as Exhibit 3.1(the “ Amended and Restated Certificate ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":0.4,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"}],"fact_type":"governance_change"},{"claim_id":"f7aa21ec6cd0dfbd397b0d7630076d21a93535af","claim":"NeuroMetrix, Inc.: The Surviving Corporation adopted Amended and Restated Bylaws in connection with the Merger.","evidence_excerpt":"At the Effective Time and in connection with the Merger, the Surviving Corporation adopted the Amended and Restated Bylaws, in the form attached hereto as Exhibit 3.2 (the “ Amended and Restated Bylaws ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":0.4,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"}],"fact_type":"governance_change"},{"claim_id":"8a3e841835a6396160cddffa0f0459a4f2e40287","claim":"NeuroMetrix, Inc. underwent a change of control involving electroCore, Inc. for $4.49 per share in cash plus one contingent value right (closed 2025-05-01).","evidence_excerpt":"the “ Merger Consideration ”). In accordance with the Merger Agreement, the Per Share Cash Consideration was determined by the Company and Parent to be in the amount of $4.49 per share of Company Common Stock. Each share of preferred stock, par value $0.001 per share, of the Company (the “ Company Preferred Stock ”) outstanding immediately prior to the","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/0001641172-25-008179-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"electroCore, Inc."},{"label":"Consideration","value":"$4.49 per share in cash plus one contingent value right"},{"label":"Closing","value":"2025-05-01"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}